Neovacs S.A jövedelem
Mi az Neovacs S.A jövedelem?
A jövedelem az Neovacs S.A. - €54.000k
Mi a jövedelem meghatározása?
A bevétel olyan jövedelem, amelyet a vállalkozásnak szokásos üzleti tevékenységéből származik, általában az áruk és szolgáltatások ügyfeleknek történő értékesítéséből.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
jövedelem a Health Care szektor a EURONEXT-on cégekben a Neovacs S.A -hoz képest
Mit csinál Neovacs S.A?
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
jövedelem -hoz hasonló cégek Neovacs S.A
- Middle Island Resources nak jövedelem AUD$52.000k van
- Emu NL nak jövedelem AUD$52.000k van
- Vango Mining nak jövedelem AUD$52.500k van
- Jadar Resources nak jövedelem AUD$53.274k van
- Elixir nak jövedelem AUD$53.344k van
- NEXE Innovations nak jövedelem CAD$53.848k van
- Neovacs S.A nak jövedelem €54.000k van
- King Island Scheelite nak jövedelem AUD$55.102k van
- Lithium Consolidated nak jövedelem AUD$55.421k van
- Sonnet BioTherapeutics Inc nak jövedelem $55.881k van
- Stroud Resources nak jövedelem CAD$56.000k van
- Global Oil & Gas nak jövedelem AUD$56.000k van
- Drumz plc nak jövedelem £56.000k van